论文部分内容阅读
在对肺性高血压患者做Swan Ganz导管术研究中,作者测定了患者对心痛定及其它心血管扩张剂的效果。结果发现两位患者对心痛定有严重副作用,后经静注氨茶碱得以逆转。例一是55岁男性患者,患不可逆慢性障碍性肺病(COPD)和肺心病,入院做SwanGanz导管术。该患有严重心衰,耐受量受到严格限制,不能接受地高辛、氨茶碱治疗。
In a Swan Ganz catheterization study of patients with pulmonary hypertension, the authors measured the effect of nifedipine and other cardiovascular dilators in patients. The results found that two patients have serious side effects of heartache, after intravenous aminophylline to be reversed. One example is a 55-year-old man with irreversible chronic obstructive pulmonary disease (COPD) and pulmonary heart disease who was admitted to hospital for SwanGanz catheterization. The suffering from severe heart failure, tolerance is severely restricted, can not accept digoxin, aminophylline treatment.